Diligence memo · auto-generated · as of July 2, 2026
SOV Therapeutics, Inc.
SOV Therapeutics, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
SOV Therapeutics, Inc. operates in Pharmaceuticals, based in MORRISVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
SOV Therapeutics, Inc. has raised $425K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $225K on 2011-11-07.
Most recent recorded round closed around 2011-11-07.
Valuation (modeled)modeled
Provath models SOV Therapeutics, Inc. at approximately $11M (range $126K–$121M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.56× the median modeled value of Pre-Seed Pharmaceuticals companies in 2010–2012 (71 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 21 months.
Last raise 14.6 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 11% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 18% of those peers.
Closest niche peers: Dermal Life, LLC, Armgo Pharma Inc, Third Day Healing Holdings LLC, Dermamedics Llc, China Yongxin Pharmaceuticals Inc..
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.